New statistical models could help to predict the risk of relapse and infection following ongoing rituximab treatment in people with…
Articles by Marisa Wexler, MS
A survey is seeking people with ANCA-associated vasculitis (AAV) around the world to help researchers better understand how patients…
Genetic variations in the TERT and DSP genes, previously associated with an increased risk of idiopathic pulmonary fibrosis (IPF),…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
People with kidney inflammation due to ANCA-associated vasculitis (AAV) have a high incidence of venous thromboembolism or VTE,…
Adding plasma exchange to immune-suppressing treatment does not significantly improve clinical outcomes in people with ANCA-associated vasculitis (AAV),…
ANCA-associated vasculitis (AAV) carries high healthcare costs for therapies and hospitalizations to treat the disease itself and related infections,…
Muscle biopsies could be used to diagnose ANCA-associated vasculitis (AAV), a new study indicates. The finding suggests that such…
Extracellular vesicles, or the tiny membrane-bound particles that are released from cells, could be used as a blood biomarker of…